Why Should You Attend:
The topic of “objectionable microorganisms” has been occupying minds of biopharmaceutical manufacturers for some time. Unfortunately, regulations are rather vague on the subject. The US drug regulations in 21 CFR211 state that drug producers must have procedures and appropriate testing to ensure that drug products are free of objectionable microorganisms, unfortunately, nothing in them helps us to understand what exactly is an “objectionable microorganism;” the interpretation is left to the organizations themselves to decide.
This lack of clear guidance from the regulators has not stopped the agency from placing a great burden upon the biopharmaceutical industry to ensure medicines are free from objectionable microorganisms. This is clearly evidenced by the recent recall data that show an increase in microbiologically-related causes. Objectionable microorganisms are especially prevalent in the recalls of non-sterile drug products. Drug manufacturers need to be concerned about the presence of objectionable microorganisms not only because of potential health hazards they may pose for patients but also due to the fact that their presence may lead to product spoilage and deterioration, which further places increased pressures on the bottom line. It is incumbent upon organizations to achieve two goals: ensure their products meet regulatory standards, and to ensure their stakeholders that they can be profitable. Mitigating the risk of presence of objectionable microorganisms in medicinal products ensures both.
Areas Covered in the Webinar:
Who Will Benefit:
All Pharmaceutical and Biotechnology companies will benefit from this webinar. The titles are:
Henry Urbach, is the founder of GMP Training, Development and Consulting, GMP TDC LLC, a New York-based consulting organization serving Life Sciences industries. He has 20+ years of Life Sciences experience having held positions of increased responsibility in GMP Training and QC Microbiology. His experience includes managing and implementing CGMP compliance and quality systems training, for major pharmaceutical and biotechnology organizations. He is a dynamic speaker specializing in FDA and ICH compliance. He is a Certified Quality Auditor. His technical education is further complemented by his BA degree in Biology and MBA, which provide a scientific and business insight. He is a member of the ASTD, ASQ, and GMP TEA, a national organization of Life Sciences training professionals.
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
6201 America Center Drive Suite 240, San Jose, CA 95002, USA
PAYMENT METHOD: 100% Secure Transaction